In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page

Changes in formulation and content of several codes from ‘The guidelines of the inspection board’ in the Netherlands

by In2Pharma | Jan 28, 2019 | News

The Netherlands After revision of the code for public advertising and medical self-care tools (CPMH), the code for the promotion of health products (CAG) and the code for advertising of medicines (CPG), various adjustments were made: To make the codes more...

Prohibition of medical claims for health products also applies to (specific combinations of) ingredients

by In2Pharma | May 23, 2018 | News

The Netherlands It is forbidden to make medical claims for healthcare products that are not registered as medicines such as food supplements. Only claims that are approved by European Food Safety Authority (EFSA), including ‘on hold’ claims for botanicals, can be...

Recent Posts

  • Reminder – update RD pregabalin/gabapentin
  • Updated deontological code animal health pharma.be
  • Cover letter variation submission
  • IML Updates Code of Ethics and Hospitality Thresholds
  • Guidance FAMHP on premiums and benefits

Follow Us

  • Facebook
  • LinkedIn
An IQVIA Business

IQVIA Logo
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations.

www.iqvia.com

Contact Us

Privacy Policy | Your Privacy Choices | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com |Terloonststraat 22, 1910 Kampenhout, België